Global Urology Drugs Market 2017 - Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022

 Published Date : Feb-2017   |    Format :PDF   |    Number of Pages : 126
Notes:
Sales, means the sales volume of Urology Drugs
Revenue, means the sales value of Urology Drugs

This report studies sales (consumption) of Urology Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
    Astellas
    Endo
    GP Pharm
    Tolmar

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Urology Drugs in these regions, from 2011 to 2021 (forecast), like
    United States
    China
    Europe
    Japan
    Southeast Asia
    India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
    a (alpha) - blockers
    5 a-reductase inhibitors
Split by applications, this report focuses on sales, market share and growth rate of Urology Drugs in each application, can be divided into
    Hospital
    Clinic

Global Urology Drugs Sales Market Report 2017
1 Urology Drugs Overview
    1.1 Product Overview and Scope of Urology Drugs
    1.2 Classification of Urology Drugs
        1.2.1 a (alpha) - blockers
        1.2.2 5 a-reductase inhibitors
    1.3 Application of Urology Drugs
        1.3.1 Hospital
        1.3.2 Clinic
    1.4 Urology Drugs Market by Regions
        1.4.1 United States Status and Prospect (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 Japan Status and Prospect (2012-2022)
        1.4.5 Southeast Asia Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Urology Drugs (2012-2022)
        1.5.1 Global Urology Drugs Sales and Growth Rate (2012-2022)
        1.5.2 Global Urology Drugs Revenue and Growth Rate (2012-2022)

2 Global Urology Drugs Competition by Manufacturers, Type and Application
     2.1 Global Urology Drugs Market Competition by Manufacturers
        2.1.1 Global Urology Drugs Sales and Market Share of Key Manufacturers (2012-2017)
        2.1.2 Global Urology Drugs Revenue and Share by Manufacturers (2012-2017)
    2.2 Global Urology Drugs (Volume and Value) by Type
        2.2.1 Global Urology Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 Global Urology Drugs Revenue and Market Share by Type (2012-2017)
    2.3 Global Urology Drugs (Volume and Value) by Regions
        2.3.1 Global Urology Drugs Sales and Market Share by Regions (2012-2017)
        2.3.2 Global Urology Drugs Revenue and Market Share by Regions (2012-2017)
    2.4 Global Urology Drugs (Volume) by Application

3 United States Urology Drugs (Volume, Value and Sales Price)
    3.1 United States Urology Drugs Sales and Value (2012-2017)
        3.1.1 United States Urology Drugs Sales and Growth Rate (2012-2017)
        3.1.2 United States Urology Drugs Revenue and Growth Rate (2012-2017)
        3.1.3 United States Urology Drugs Sales Price Trend (2012-2017)
    3.2 United States Urology Drugs Sales and Market Share by Manufacturers
    3.3 United States Urology Drugs Sales and Market Share by Type
    3.4 United States Urology Drugs Sales and Market Share by Application

4 China Urology Drugs (Volume, Value and Sales Price)
    4.1 China Urology Drugs Sales and Value (2012-2017)
        4.1.1 China Urology Drugs Sales and Growth Rate (2012-2017)
        4.1.2 China Urology Drugs Revenue and Growth Rate (2012-2017)
        4.1.3 China Urology Drugs Sales Price Trend (2012-2017)
    4.2 China Urology Drugs Sales and Market Share by Manufacturers
    4.3 China Urology Drugs Sales and Market Share by Type
    4.4 China Urology Drugs Sales and Market Share by Application

5 Europe Urology Drugs (Volume, Value and Sales Price)
    5.1 Europe Urology Drugs Sales and Value (2012-2017)
        5.1.1 Europe Urology Drugs Sales and Growth Rate (2012-2017)
        5.1.2 Europe Urology Drugs Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Urology Drugs Sales Price Trend (2012-2017)
    5.2 Europe Urology Drugs Sales and Market Share by Manufacturers
    5.3 Europe Urology Drugs Sales and Market Share by Type
    5.4 Europe Urology Drugs Sales and Market Share by Application

6 Japan Urology Drugs (Volume, Value and Sales Price)
    6.1 Japan Urology Drugs Sales and Value (2012-2017)
        6.1.1 Japan Urology Drugs Sales and Growth Rate (2012-2017)
        6.1.2 Japan Urology Drugs Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Urology Drugs Sales Price Trend (2012-2017)
    6.2 Japan Urology Drugs Sales and Market Share by Manufacturers
    6.3 Japan Urology Drugs Sales and Market Share by Type
    6.4 Japan Urology Drugs Sales and Market Share by Application
7 Southeast Asia Urology Drugs (Volume, Value and Sales Price)
    7.1 Southeast Asia Urology Drugs Sales and Value (2012-2017)
        7.1.1 Southeast Asia Urology Drugs Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Urology Drugs Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Urology Drugs Sales Price Trend (2012-2017)
    7.2 Southeast Asia Urology Drugs Sales and Market Share by Manufacturers
    7.3 Southeast Asia Urology Drugs Sales and Market Share by Type
    7.4 Southeast Asia Urology Drugs Sales and Market Share by Application
8 India Urology Drugs (Volume, Value and Sales Price)
    8.1 India Urology Drugs Sales and Value (2012-2017)
        8.1.1 India Urology Drugs Sales and Growth Rate (2012-2017)
        8.1.2 India Urology Drugs Revenue and Growth Rate (2012-2017)
        8.1.3 India Urology Drugs Sales Price Trend (2012-2017)
    8.2 India Urology Drugs Sales and Market Share by Manufacturers
    8.3 India Urology Drugs Sales and Market Share by Type
    8.4 India Urology Drugs Sales and Market Share by Application

9 Global Urology Drugs Manufacturers Analysis
    9.1 Astellas
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Urology Drugs Product Type, Application and Specification
            9.1.2.1 a (alpha) - blockers
            9.1.2.2 5 a-reductase inhibitors
        9.1.3 Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Endo
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Urology Drugs Product Type, Application and Specification
            9.2.2.1 a (alpha) - blockers
            9.2.2.2 5 a-reductase inhibitors
        9.2.3 Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 GP Pharm
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Urology Drugs Product Type, Application and Specification
            9.3.2.1 a (alpha) - blockers
            9.3.2.2 5 a-reductase inhibitors
        9.3.3 GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Tolmar
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Urology Drugs Product Type, Application and Specification
            9.4.2.1 a (alpha) - blockers
            9.4.2.2 5 a-reductase inhibitors
        9.4.3 Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview

10 Urology Drugs Maufacturing Cost Analysis
    10.1 Urology Drugs Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Urology Drugs
    10.3 Manufacturing Process Analysis of Urology Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Urology Drugs Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Urology Drugs Major Manufacturers in 2015
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Urology Drugs Market Forecast (2017-2022)
    14.1 Global Urology Drugs Sales, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Urology Drugs Sales and Growth Rate Forecast (2017-2022)
       14.1.2 Global Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Urology Drugs Price and Trend Forecast (2017-2022)
    14.2 Global Urology Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.1 United States Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
       14.2.2 China Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
       14.2.3 Europe Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 Japan Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Southeast Asia Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 India Urology Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Urology Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
    14.4 Global Urology Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    Methodology
    Analyst Introduction
    Data Source



List of Tables and Figures

Figure Picture of Urology Drugs
Table Classification of Urology Drugs
Figure Global Sales Market Share of Urology Drugs by Type in 2015
Figure a (alpha) - blockers Picture
Figure 5 a-reductase inhibitors Picture
Table Applications of Urology Drugs
Figure Global Sales Market Share of Urology Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Urology Drugs Revenue and Growth Rate (2012-2022)
Figure China Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Urology Drugs Revenue and Growth Rate (2012-2022)
Figure India Urology Drugs Revenue and Growth Rate (2012-2022)
Figure Global Urology Drugs Sales and Growth Rate (2012-2022)
Figure Global Urology Drugs Revenue and Growth Rate (2012-2022)
Table Global Urology Drugs Sales of Key Manufacturers (2012-2017)
Table Global Urology Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Urology Drugs Sales Share by Manufacturers
Figure 2016 Urology Drugs Sales Share by Manufacturers
Table Global Urology Drugs Revenue by Manufacturers (2012-2017)
Table Global Urology Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Urology Drugs Revenue Share by Manufacturers
Table 2016 Global Urology Drugs Revenue Share by Manufacturers
Table Global Urology Drugs Sales and Market Share by Type (2012-2017)
Table Global Urology Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Urology Drugs by Type (2012-2017)
Figure Global Urology Drugs Sales Growth Rate by Type (2012-2017)
Table Global Urology Drugs Revenue and Market Share by Type (2012-2017)
Table Global Urology Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Urology Drugs by Type (2012-2017)
Figure Global Urology Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Urology Drugs Sales and Market Share by Regions (2012-2017)
Table Global Urology Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Urology Drugs by Regions (2012-2017)
Figure Global Urology Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Urology Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Urology Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Urology Drugs by Regions (2012-2017)
Figure Global Urology Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Urology Drugs Sales and Market Share by Application (2012-2017)
Table Global Urology Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Urology Drugs by Application (2012-2017)
Figure Global Urology Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Urology Drugs Sales and Growth Rate (2012-2017)
Figure United States Urology Drugs Revenue and Growth Rate (2012-2017)
Figure United States Urology Drugs Sales Price Trend (2012-2017)
Table United States Urology Drugs Sales by Manufacturers (2012-2017)
Table United States Urology Drugs Market Share by Manufacturers (2012-2017)
Table United States Urology Drugs Sales by Type (2012-2017)
Table United States Urology Drugs Market Share by Type (2012-2017)
Table United States Urology Drugs Sales by Application (2012-2017)
Table United States Urology Drugs Market Share by Application (2012-2017)
Figure China Urology Drugs Sales and Growth Rate (2012-2017)
Figure China Urology Drugs Revenue and Growth Rate (2012-2017)
Figure China Urology Drugs Sales Price Trend (2012-2017)
Table China Urology Drugs Sales by Manufacturers (2012-2017)
Table China Urology Drugs Market Share by Manufacturers (2012-2017)
Table China Urology Drugs Sales by Type (2012-2017)
Table China Urology Drugs Market Share by Type (2012-2017)
Table China Urology Drugs Sales by Application (2012-2017)
Table China Urology Drugs Market Share by Application (2012-2017)
Figure Europe Urology Drugs Sales and Growth Rate (2012-2017)
Figure Europe Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Urology Drugs Sales Price Trend (2012-2017)
Table Europe Urology Drugs Sales by Manufacturers (2012-2017)
Table Europe Urology Drugs Market Share by Manufacturers (2012-2017)
Table Europe Urology Drugs Sales by Type (2012-2017)
Table Europe Urology Drugs Market Share by Type (2012-2017)
Table Europe Urology Drugs Sales by Application (2012-2017)
Table Europe Urology Drugs Market Share by Application (2012-2017)
Figure Japan Urology Drugs Sales and Growth Rate (2012-2017)
Figure Japan Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Urology Drugs Sales Price Trend (2012-2017)
Table Japan Urology Drugs Sales by Manufacturers (2012-2017)
Table Japan Urology Drugs Market Share by Manufacturers (2012-2017)
Table Japan Urology Drugs Sales by Type (2012-2017)
Table Japan Urology Drugs Market Share by Type (2012-2017)
Table Japan Urology Drugs Sales by Application (2012-2017)
Table Japan Urology Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Urology Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Urology Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Urology Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Urology Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Urology Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Urology Drugs Sales by Type (2012-2017)
Table Southeast Asia Urology Drugs Market Share by Type (2012-2017)
Table Southeast Asia Urology Drugs Sales by Application (2012-2017)
Table Southeast Asia Urology Drugs Market Share by Application (2012-2017)
Figure India Urology Drugs Sales and Growth Rate (2012-2017)
Figure India Urology Drugs Revenue and Growth Rate (2012-2017)
Figure India Urology Drugs Sales Price Trend (2012-2017)
Table India Urology Drugs Sales by Manufacturers (2012-2017)
Table India Urology Drugs Market Share by Manufacturers (2012-2017)
Table India Urology Drugs Sales by Type (2012-2017)
Table India Urology Drugs Market Share by Type (2012-2017)
Table India Urology Drugs Sales by Application (2012-2017)
Table India Urology Drugs Market Share by Application (2012-2017)
Table Astellas Basic Information List
Table Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Urology Drugs Global Market Share (2012-2017)
Table Endo Basic Information List
Table Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Endo Urology Drugs Global Market Share (2012-2017)
Table GP Pharm Basic Information List
Table GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GP Pharm Urology Drugs Global Market Share (2012-2017)
Table Tolmar Basic Information List
Table Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Tolmar Urology Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urology Drugs
Figure Manufacturing Process Analysis of Urology Drugs
Figure Urology Drugs Industrial Chain Analysis
Table Raw Materials Sources of Urology Drugs Major Manufacturers in 2015
Table Major Buyers of Urology Drugs
Table Distributors/Traders List
Figure Global Urology Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Urology Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Urology Drugs Sales Forecast by Regions (2017-2022)
Table Global Urology Drugs Sales Forecast by Type (2017-2022)
Table Global Urology Drugs Sales Forecast by Application (2017-2022)

Latest News

21-Nov-2017 | Chemicals & Materials

Awareness Regarding Health and Hygiene To Spur The Medical Gloves Market

The key factor contributing to the growth of the medical gloves is the rising alertness of safety and health measures that have to be implemented with the purpose of preventing the spread of diseases. Medical disposable gloves are utilized in carrying out medical examinations and procedures to aid in preventing probable contamination between patients and healthcare personnel. They are gloves th ...

21-Nov-2017 | Healthcare

Development of Cutting-Edge Innovation to Recreate the Outline of Healthcare Equipment Market

Innovation, this one wording has definitely developed the method for organizations, evolving advancements, and economies. It is considered as a compulsory mechanism to streamline the hardest difficulties.

15-Nov-2017 | Consumer Goods & Retailing

Chinese Goods Sale To Witness A Huge Fall Of 40–45% In The Indian Market On Festive Season

For the last few years, Chinese products have done an appreciable business in terms of Diwali. But in this festive season, especially Diwali Chinese product can be a major drop in sales. From lights to gifts to Diwali and home decoration, a majority of the products are imported from China. Sales of Chinese products can be reduced by 40% to 45% this year compared to last year. This is revealed i ...

15-Nov-2017 | Medical Devices

Growing Rate of High-Risk Pregnancies to Spur the Fetal Monitoring Devices Market

Fetal monitoring signifies to the electronic monitoring of the patient. It registers the fetus’ vital physiological functions and the contractions of the uterus of the mother during birth and pregnancy. These monitors are bedside units that consist of an observing monitoring unit, electrodes, and cables. They record, measure, and present FHR, maternal heart rate &BP during and before ...

06-Nov-2017 | Chemicals & Materials

Declining Use of Cigarettes to Drive the Smokeless Tobaccos Market

Owing to unrelenting attempts from the health organizations and governments across the world, the number of people smoking has been declined; nevertheless, the smokeless tobacco products dodging the regulatory spectacle have seen a stable increase in consumption. Even though smokeless tobaccos were recognized to confront the combustible cigarette market, the introduction of Big Tobacco transfor ...